Clin2
NCT06812832Possibly a fitRecruiting

Simethicone in bariatric surgery recovery

SimethiconeBariatric SurgeryPost-operative Pain

Part of Pain clinical trials.

This trial tests if giving simethicone (a gas-relief medication) as part of a standard recovery plan helps patients feel better after weight-loss surgery. It may reduce bloating and discomfort after surgery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
260 people
Ages
18 years to 89 years
Study type
Interventional

Who can take part

  • You are scheduled for a foregut procedure (weight-loss surgery that reroutes your stomach or intestines).
  • You are 18 years or older.
  • You are not pregnant or breastfeeding.
  • You do not have an allergy to simethicone (Gas-X or similar products).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04581447Recruiting· Phase 3
Metformin to help prevent diabetes returning after weight surgery

This Phase 3 study tests whether adding metformin after gastric bypass or sleeve surgery can help you stay free of diabetes for longer. It compares metformin plus standard care versus standard care alone.

Amiens
NCT03490630Recruiting
Survey study after bariatric weight-loss surgery

This study asks adults to complete patient-reported surveys after elective bariatric (weight-loss) surgery. It may help doctors better understand how patients experience recovery and outcomes.

Bern
NCT05472922Recruiting
Small stomach bypass surgery for weight loss

This trial compares a “mini” gastric bypass procedure to help with weight loss in adults who qualify for bariatric (weight-loss) surgery. It’s testing whether the approach works well and is safe for people who meet the study requirements.

Almelo
NCT06789614Not yet recruiting
Comparing two anti-nausea drugs before weight-loss surgery

This trial compares two medications, cyclizine and metoclopramide, given before bariatric surgery to see which one better reduces the amount of fluid left in the stomach (gastric residual volume). This matters because a full stomach during surgery can increase the risk of complications. If you qualify, you'll receive one of these medications randomly, and the results may help improve safety for future patients.

NCT07539623Recruiting· Phase 3
Pain relief with suzetrigine after heart or weight-loss surgery

This study tests whether suzetrigine, a new pain medication, can reduce the need for opioids (strong painkillers) after cardiac or bariatric surgery. The goal is to help patients manage pain with fewer opioid-related side effects.

New York, New York
NCT06915558Recruiting
Reducing inflammation in weight loss surgery

This trial tests a method to control inflammation during bariatric surgery. It may help patients recover better and have fewer complications.

Barcelona, Barcelona

Hear when a new Bariatric Surgery trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.